4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-040975
Chief Financial Officer sold 2,500 shares at $20.00 ($50,000)
From the SEC's structured data for this filing
Trades in this filing
RAY DEBANJAN · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-01 | Sale : show line 1 in the form | −2,500 | $20.00 | $50,000 | 12,126 | D |
| Open-market sales · 2,500 sh · avg $20.00 · $50,000 | ||||||
Loading xslF345X03/doc1.xml…